<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Baltina, L.A.</author>
     <author>Stolyarova, O.V.</author>
     <author>Kondratenko, R.M.</author>
     <author>Gabbasov, T.M.</author>
     <author>Baltina, L.A.</author>
     <author>Plyasunova, O.A.</author>
     <author>Il’ina, T.V.</author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2014</year>
    <pub-dates>
     <date>2018-03-14</date>
    </pub-dates>
   </dates>
   <abstract>The glycyrrhizic acid (GA) analog olean-9(11),12(13)-dien-30-oic acid 3β-(2-O-β-D-glucuronopyranosyl-β-D-glucuronopyranoside) (II) was synthesized via reduction of GA by NaBH4 in refluxing 2-PrOH:H2O with subsequent work up with HCl (5%). The cytotoxicity and antiviral activity of this glycoside against HIV-1 was studied in MT-4 cell culture. It was found that II was practically non-toxic for MT-4 cells while inhibiting accumulation of virus-specific protein p24 and RNA-dependent DNA-polymerase activity of HIV-1 reverse transcriptase (RT) (IC50 3.1 ±1.0 μg/mL).</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/767</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/883</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
